As shown in Figures 4(a) and 4(b), a significant decrease in GPX4 expression was observed in the PCOS and erastin groups while NF-κB expression was significantly increased in both groups compared to the control group. The gene discussed is GPX4; the disease is polycystic ovary syndrome.